ALX Oncology
ALXO
ALXO
89 hedge funds and large institutions have $2.78B invested in ALX Oncology in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
36% more call options, than puts
Call options by funds: $551K | Put options by funds: $405K
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
8.07% more ownership
Funds ownership: 73.71% → 81.78% (+8.1%)
Holders
89
Holding in Top 10
6
Calls
$551K
Puts
$405K
Top Buyers
| 1 | +$99.9M | |
| 2 | +$81.8M | |
| 3 | +$47.7M | |
| 4 |
BlackRock
New York
|
+$46.9M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$36.8M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$11.3M | |
| 3 | -$8.46M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.44M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.76M |